Get all 12 Stocks in Keith's FREE Report here: https://www.marketbeat.com/y/yt1012/
ChatGPT changed workplaces forever, and robots will change them even more, but this next wave of AI could change humanity forever. TradeSmith's Keith Kaplan joins MarketBeat's Bridget Bennett to break down the next huge wave of AI advancement, how AI is learning to read, rewrite, and replace parts of the human body, and the 4 stocks to buy in the space.
Keith shares a story of AI giving a woman her voice back after years of silence, explains why he believes this area of AI has a market that will never run out of customers, and walks through how he builds a basket of stocks by risk, from the steadier names to the most speculative ones.
Best AI stocks to buy now, biointelligence stocks, healthcare AI stocks, biotech stocks to buy now, AI in healthcare, and how to invest in the next wave of AI, all in this stock market update.
Chapters:
0:00 Introduction
3:40 How AI Is Rewriting the Human Body
12:22 Stock 1
15:40 Stock 2
19:32 Stock 3
24:20 Stock 4
View Bridget's Buys here: https://www.marketbeat.com/bridget
📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks.
For YouTube sponsorships, brand partnerships and advertising, send an email to: youtube@marketbeatmail.com
DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.
